On the basis of our experience, we would suggest that control of HIV-RNA viremia in liver transplanted patients is still a matter of the choice of the best ART independently from the type of the antirejection treatment; moreover, the use of rapamycin in this context may bemisleading because it has been already clearly demonstrated that ART has an impact on overall survival in HIV-positive liver transplanted patients.

mTOR immunosuppression in HIV-positive liver transplant recipients

GROSSI, PAOLO ANTONIO;
2010-01-01

Abstract

On the basis of our experience, we would suggest that control of HIV-RNA viremia in liver transplanted patients is still a matter of the choice of the best ART independently from the type of the antirejection treatment; moreover, the use of rapamycin in this context may bemisleading because it has been already clearly demonstrated that ART has an impact on overall survival in HIV-positive liver transplanted patients.
2010
HIV; liver transplantation; mTOR inhibitors; hepatocellular carcinoma; antiretroviral therapy
Baccarani, U; Adani, Gl; Tavio, M; Grossi, PAOLO ANTONIO; Viale, P.
File in questo prodotto:
File Dimensione Formato  
mTOR immunosuppression il HIV-positive liver transplant recipients.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: DRM non definito
Dimensione 82.37 kB
Formato Adobe PDF
82.37 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/1743304
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact